PRISM Registry: Pseudobulbar Affect Registry Series
Status: | Completed |
---|---|
Conditions: | Alzheimer Disease, Parkinsons Disease, Hospital, Neurology, ALS |
Therapuetic Areas: | Neurology, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 5/3/2014 |
Start Date: | May 2011 |
End Date: | December 2011 |
Contact: | Randall Kaye, MD |
Phone: | 1-855-472-2722 |
PBA is a neurologic condition that is estimated to impact over a million patients and their
families in the United States. PBA occurs secondary to an otherwise unrelated neurologic
disease or injury, and manifests as involuntary, frequent, and disruptive outbursts of
crying and/or laughing. Progress has been made in better understanding this debilitating
condition, but much more needs to be done. That's why a new PBA patient registry, PRISM
(Pseudobulbar Affect RegIstry Series), has been initiated.
The goal of PRISM is to establish the prevalence and quality of life (QOL) impact of PBA in
patients with underlying neurologic conditions including
- Alzheimer's disease
- Amyotrophic lateral sclerosis
- Multiple sclerosis
- Parkinson's disease
- Stroke
- Traumatic brain injury
Because this is an observational registry, it doesn't require you to intervene with any
specific treatment or procedure. Your participation allows the PRISM registry to collect and
analyze data from your site and also compare it to national numbers captured in the PRISM
registry about PBA across all of the major at-risk neurologic populations.
families in the United States. PBA occurs secondary to an otherwise unrelated neurologic
disease or injury, and manifests as involuntary, frequent, and disruptive outbursts of
crying and/or laughing. Progress has been made in better understanding this debilitating
condition, but much more needs to be done. That's why a new PBA patient registry, PRISM
(Pseudobulbar Affect RegIstry Series), has been initiated.
The goal of PRISM is to establish the prevalence and quality of life (QOL) impact of PBA in
patients with underlying neurologic conditions including
- Alzheimer's disease
- Amyotrophic lateral sclerosis
- Multiple sclerosis
- Parkinson's disease
- Stroke
- Traumatic brain injury
Because this is an observational registry, it doesn't require you to intervene with any
specific treatment or procedure. Your participation allows the PRISM registry to collect and
analyze data from your site and also compare it to national numbers captured in the PRISM
registry about PBA across all of the major at-risk neurologic populations.
Inclusion Criteria:
- All participants must have underlying neurologic conditions known to be risk factors
of PBA: Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis,
Parkinson's Disease, Stroke, and Traumatic Brain Injury.
- The population for this study will be 18 years and over
We found this trial at
1
site
Click here to add this to my saved trials